GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Biolife Sciences Inc (OTCPK:BLFE) » Definitions » Net Income Including Noncontrolling Interests

Biolife Sciences (Biolife Sciences) Net Income Including Noncontrolling Interests : $-2.68 Mil (TTM As of May. 2008)


View and export this data going back to 2005. Start your Free Trial

What is Biolife Sciences Net Income Including Noncontrolling Interests?

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Biolife Sciences's Net Income Including Noncontrolling Interests for the three months ended in May. 2008 was $-0.84 Mil. Its Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in May. 2008 was $-2.68 Mil.

Biolife Sciences Net Income Including Noncontrolling Interests Historical Data

The historical data trend for Biolife Sciences's Net Income Including Noncontrolling Interests can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biolife Sciences Net Income Including Noncontrolling Interests Chart

Biolife Sciences Annual Data
Trend Nov04 Nov05 Nov06 Nov07
Net Income Including Noncontrolling Interests
-0.02 -1.51 -0.29 -2.05

Biolife Sciences Quarterly Data
Nov04 Feb05 May05 Aug05 Nov05 Feb06 May06 Aug06 Nov06 Feb07 May07 Aug07 Nov07 Feb08 May08
Net Income Including Noncontrolling Interests Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.46 -0.36 -1.03 -0.45 -0.84

Biolife Sciences Net Income Including Noncontrolling Interests Calculation

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in May. 2008 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.68 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biolife Sciences Net Income Including Noncontrolling Interests Related Terms

Thank you for viewing the detailed overview of Biolife Sciences's Net Income Including Noncontrolling Interests provided by GuruFocus.com. Please click on the following links to see related term pages.

Biolife Sciences (Biolife Sciences) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Biolife Sciences Inc (OTCPK:BLFE) » Definitions » Net Income Including Noncontrolling Interests
Comparable Companies
WAR:ERS TWER TSXV:VMY.H BOM:538674 FULO WAR:ECL ASX:REF TSXV:ECT XSAT:CHAL B WAR:AIT NSE:ACCORD WAR:TLG XCNQ:RVR DTGI OSTO:WIFOG WAR:U2K BOM:511116 ASX:ZIP JSE:TLM WAR:SFN
Traded in Other Exchanges
N/A
Address
2831 Street Rose Parkway, No. 200, Henderson, NV, USA, 89052
Website
https://www.biolifesciences.com
Biolife Sciences Inc is a commercialization accelerator, licensor and developer of innovative and disruptive technologies for the healthcare, beauty and food and beverage industry sectors. The company's technologies include antimicrobial copper air filters and copper-infused textiles. Its revenues are primarily generated from the sale of sanitation products.
Executives
Arthur Viola director, 10 percent owner, officer: CEO

Biolife Sciences (Biolife Sciences) Headlines

From GuruFocus

Rhino Novi Announces Name Change and New CEO

By Marketwired Marketwired • 09-15-2020